Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-26 @ 10:17 PM
Study NCT ID:
NCT01287312
Status:
UNKNOWN
Last Update Posted:
2011-02-01
First Post:
2011-01-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Trichloroacetic Acid for Endoscopic Tracho-esophageal Fistula Repair
Sponsor:
Hadassah Medical Organization
Organization:
Study Overview
Official Title:
Trichloroacetic Acid for Endoscopic Tracho-esophageal Fistula Repair
Status:
UNKNOWN
Status Verified Date:
2011-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure. Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported with a good results ( 4 cases). There were no serious advers effects.
The investigators want to use also TCA 50% for endoscopic repair in children with recurrent TEF.
The investigators want to use also TCA 50% for endoscopic repair in children with recurrent TEF.
Detailed Description:
Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure. Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported with a good results ( 4 cases). There were no serious advers effects.
We want to use also TCA 50% for endoscopic repair in children with recurrent TEF.
We want to use also TCA 50% for endoscopic repair in children with recurrent TEF.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: